Carsten Boess

Carsten Boess was the founder of Kiniksa Pharmaceuticals Ltd., founded in 2015, where the title held was Executive Vice President-Corporate Affairs from 2015 to 2020.
Current jobs include Director at Atrium Therapeutics, Inc. since 2026, Independent Director at Rocket Pharmaceuticals, Inc. since 2016, and Independent Non-Executive Director at Achilles Therapeutics Plc since 2020.
Former jobs include Non-Executive Director at Achilles Therapeutics UK Ltd. from 2020 to 2021, Senior Director-Finance & Information Technology at Novozymes A, Independent Director at Inotek Pharmaceuticals Corp., Independent Director at Health Sciences Acquisitions Corp.
2, Independent Director at Avidity Biosciences, Inc. from 2020 to 2026, Chief Financial Officer at Alexion Pharmaceuticals, Inc. from 2004 to 2005, Vice President-Finance & International Operations at Novo Nordisk A from 1991 to 2004, Executive Vice President-Finance at EMD Serono, Inc. from 2005 to 2006, Manager-Investor Relations & Finance at Novo Nordisk North America, Inc., and Chief Financial Officer & Senior Vice President at Synageva BioPharma Corp.
from 2011 to 2015.
Education includes undergraduate and graduate degrees from the University of Southern Denmark.